Lee, S.E.; Park, J.-H.; Kim, D.; Lee, H.-A.; Kang, Y.S.; Yoon, Y.S.; Jeong, Y.J.; Choi, H.S.; Kim, K.-A.
Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy. Biomedicines 2025, 13, 1101.
https://doi.org/10.3390/biomedicines13051101
AMA Style
Lee SE, Park J-H, Kim D, Lee H-A, Kang YS, Yoon YS, Jeong YJ, Choi HS, Kim K-A.
Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy. Biomedicines. 2025; 13(5):1101.
https://doi.org/10.3390/biomedicines13051101
Chicago/Turabian Style
Lee, Seung Eun, Ju-Hyun Park, Dalyong Kim, Hyun-A Lee, Yun Seong Kang, Young Soon Yoon, Yun Jeong Jeong, Han Seok Choi, and Kyoung-Ah Kim.
2025. "Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy" Biomedicines 13, no. 5: 1101.
https://doi.org/10.3390/biomedicines13051101
APA Style
Lee, S. E., Park, J.-H., Kim, D., Lee, H.-A., Kang, Y. S., Yoon, Y. S., Jeong, Y. J., Choi, H. S., & Kim, K.-A.
(2025). Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy. Biomedicines, 13(5), 1101.
https://doi.org/10.3390/biomedicines13051101
